We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Verona Pharma Plc | LSE:VRP | London | Ordinary Share | GB00BYW2KH80 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 55.00 | 45.00 | 65.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
01/9/2020 16:37 | ..this really is a dissapointing and miserable little stock! | haff1 | |
26/8/2020 19:25 | ...... shares as insentive for doing what exactly? Just being there? Its discusting this riping off shareholders money so that they get freebees? When are they actually going to get this up and running? If by May 2021 we havent got a large pharma securely signed up to fund this going forward are they going to give those shares back!!!? | haff1 | |
25/8/2020 22:12 | Good to see a bit of BLUE. Is a partnership deal possible this year.... possible. But if successful covid trials it becomes a whole lot more probable and big jump in SP | shakin not stirred | |
21/8/2020 10:50 | Usual jam tomorrow drop back to where it was....It would be good to see this actually go up and hold for once. If it has the potential claimed isn't it about time some larger company was taking a serious interest? ....but it doesnt seem to be! | haff1 | |
19/8/2020 08:17 | typo 12 should be 6. I hasten to add that if they had been on the ball. The placing would have happened at £1 to £2 and not 45p.When will the board start to be a bit more proactive and intelligent in their decisions Extra dilution for us share holders. They would think twice if they ever actually bought lots of shares but alas that is something that only our chairman has done. Sums up the company unfortunately as they continue to stumble like a punch drunk boxer. Maybe this new CEO will turn it around as he has been handsomely paid already. | shakin not stirred | |
19/8/2020 08:10 | Bonzo covid 19 treatment opportunity was 12 months ago.They have never that I can recall made the correct decision. However the wind of fortune has to change at some point. With all the news due this should be £1.50- £2. But this is VRP after all. | shakin not stirred | |
17/8/2020 08:33 | Just up, stay & hold for a year or two imho | ny boy | |
17/8/2020 08:19 | Back to the £1.50s + :) | bewise2 | |
14/8/2020 16:08 | 70'sBack to 40's soon | pjm1162 | |
14/8/2020 08:09 | ...after a visit to the 90's | tradertrev | |
14/8/2020 06:12 | I am also pleased to announce that we have received a notice to proceed for our Investigational New Drug ("IND") from the FDA to study ensifentrine in patients with COVID-19. We plan to initiate a randomized, double-blind, placebo-controlled pilot clinical study to evaluate ensifentrine delivered via pressurized metered-dose inhaler ("pMDI") formulation as a treatment for patients hospitalized with COVID-19 at the University of Alabama at Birmingham. Clinical data from prior studies of ensifentrine in other respiratory diseases have demonstrated ensifentrine improves lung function and reduces cellular markers of inflammation in the lungs. We believe ensifentrine, with its novel mechanism of action, has the potential to improve oxygenation and lung function assisting recovery from COVID-19. | goggin | |
14/8/2020 06:07 | Now here's an idea. An inhaler treatment for early stage COVID. That would be amazing... | bonzo | |
14/8/2020 06:04 | Glad to see they have woken up to the COVID treatment opportunity. This is a much bigger market opp than COPD and the drug should work well... | bonzo | |
13/8/2020 16:50 | Dr R potentially looks like you may have.Does not seem to long before we get to the 45p placement share price Yes Timbo has good posts and sold up a chunck I believe when they missed a golden opportunity. I hasten to add that the Uk management received riduculously high renumeration for what little they achieved during their failed reign.However in balance the USA management have in the short time received even more renumeration for doing nothing so far. Other than a placing at no premium, yet they say we have a premium product. Dr Z has been awarded 3% of the company shares and it appears that we are left with a very poor percentage of the funding. That must have some seriously large admin and arrangement fees that I have ever seen.I would like to see the company accounts and the auditors allocation of costs for that onein year end accounts which I Will scrutinise with the eye of an eagle and ask any relevant questions at the next AGM. | shakin not stirred | |
13/8/2020 15:18 | I hope by posting I haven't hastened its move down to 45p!! | drradcliffe | |
13/8/2020 14:08 | There is so much bad history here. I've lost most times I have bought and sold this over the years. It's now essentially a US company. Previous UK management have drawn significant salaries and options and haven't progressed development nearly as much as they should have done. But, one day it could easily come good. It's a bit of a "horse racing" type share. It could go down to the 45p placement price, it's pretty illiquid. Shares like this are volatile. But they are just about to enter phase 3 and have a decent number of life science funds invested. Anyone thinking of investing should look at the August presentation, read some of the previous posts (Timbo's are always good) and weigh up the odds. | drradcliffe | |
13/8/2020 13:36 | tom greg. Not anymore. Back to the PLACING share price Sell high which is now and the buy low placing. No news for a very long time as sweet FA happening here as per usual. | shakin not stirred | |
11/8/2020 23:04 | Well Timbo you will probably be purchasing more as the price has only been worked higher so those in the latest fund raise can exit hence the big price drop in the USA today. The Yanks will eventually cotton on to the pattern that this share price follows. Sell high and buy low. This is to be traded to get any money from your investment.I too will top up at placement price.When we have lost so many chief medical officers it really tells the true picture. The share price even at £1 should be lunacy but so often the market has it correct more often than the investors and the share price is where it is due to poor direction and lost opportunities. This company is great if you are on the payroll otherwise totally uninspiring in all they do. Glad you are still about Timbo. Expecting that we will both get the chance to top up below the placing price this side of Christmas. | shakin not stirred | |
11/8/2020 14:03 | Shakin' No, I am still here and invested, but I am not inclined to buy any more right now, if they drift back to the placing price, I may be tempted. I think the management did lose their way focusing on the DPI and MDI formats a while back, however reading between the lines of the funding RNS, it seems they are now concentrating on the nebulized (single active) solution, which IMO they should have done all along. For what it's worth I do not think it will ever be sold as a combo with a LABA or LAMA as the duration of action seems to be around 6 hours which is insufficient to combine with other actives which have a duration of action of 10 - 12 hours. | timbo003 | |
11/8/2020 13:51 | Looking better in the US @ 8.62 - 68 - Equivalent of 82-83 right now. | tomgreg | |
10/8/2020 23:56 | presuming even Timbo has sold up. At least in 2023 we will know if it is boom or busted.Disappointing however you wish to look at it unless you are smart enough to have traded it. I believe more pi's will dump once it gets over a quid knowing that you can buy back equivalent shares for 60% of the price in all reality. | shakin not stirred | |
10/8/2020 23:48 | haff1 You have to laugh as the latest webcast reads not even Jam tomorrow anymore. Now managing to stretch this out to commercialization in 2023 to 2024. Having just totally diluted all shareholders even further at a pathetic placing price with huge costs incurred. This will rise to about £1 to £1.20 and USA equivalent to let the recent institutional investors exit with a decent profit and then drop down I expect to the placing price. Most manipulated stock ever. I will sell at £1 and then buy back in when the share price returns to placing amount or lower. Should think they now have enough capital raised to pay their salaries until 2023. Then expect them to take it private for less than £1. Watch and learn as my old man used to say. Follows same pattern and hence why very little interest from pi's. GLA if this goes above £1.20 I am out for good. Worst pharma share I ever invested in and lets be honest the drug cannot be all that as still no partners of which we have always been talking to. it is like a circus. | shakin not stirred | |
05/8/2020 13:52 | shakin not stirred30 Jul '20 - 09:41 - 1322 of 1325 0 0 0 bbonsall. Each fund raise they have said that it is so that they are in a position of strength to negotiate and nothing yet so I do not expext any different. More likely they will go on their own and work the share price right down and then give a pittance and take it private.Your last paragraph would be true except the first global funding saw an army of ip lawyers etc etc look at the data room and they are all sitting on huge losses so what they invest actually means very little and certainly once the3 and 6 month figures are out and we see the salary drain on finances and probably large administrative costs as usual then we shall start to see the slide back to 45p. The placing. It will make no difference as the mm's will benefit and at the end of the day and next year they will raise it to 31 again and make a killing and then all the way back down again. Cannot believe that more investors have not sold if sold today you more than likely can buy back 50% more once it drops to 50p.This should slow drip till Friday.When does the new stock hit the market as that could be a bad day but if a slow drift down may avert the sudden massive percentage drop in share price Nothing really going to happen her until this time next year so a nice drip feed drop expected.I have seen placings made at higher prices than current share price but never with this company. Says it all.Confidence not there for whatever reason. Lack of investing from the big boy, however they may purchase once this drops to 50p again and then maybe not as they did not last time. They just seem to prefer their free options doled out by the company ——— IConcur | andymunchkin | |
30/7/2020 15:37 | Huge sell this was at over 100p, it still is now, 100% sure you'll see 50 soon | pjm1162 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions